Endeavor Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$832K Buy
2,364
+60
+3% +$21.4K 0.24% 83
2025
Q4
$754K Sell
2,304
-183
-7% -$58K 0.22% 90
2025
Q3
$702K Sell
2,487
-59
-2% -$17.1K 0.22% 94
2025
Q2
$711K Sell
2,546
-407
-14% -$115K 0.34% 62
2025
Q1
$920K Buy
2,953
+2,377
+413% +$702K 0.5% 51
2024
Q4
$150K Buy
+576
New +$171K 0.14% 67

Other funds holding AMGN

Endeavor Private Wealth's AMGN Position: Q1 2026 in Review

Endeavor Private Wealth increased its Amgen (AMGN) stake by 2.6% in Q1 2026, buying an estimated $21.4K and bringing the position to 2,364 shares worth $832K. The position accounts for 0.24% of the portfolio, ranked #83.

Endeavor Private Wealth first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. The position peaked at $920K in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Endeavor Private Wealth held 2,364 shares of Amgen worth $832K as of Q1 2026.
  • Endeavor Private Wealth bought 60 Amgen shares in Q1 2026, an estimated $21.4K.
  • Amgen made up 0.24% of Endeavor Private Wealth's portfolio in Q1 2026, its #83 holding.
  • Endeavor Private Wealth first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • Endeavor Private Wealth's Amgen position peaked at $920K in Q1 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Endeavor Private Wealth's 13F filing for Q1 2026, filed 14 May 2026.